Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events
作者： Jeanine E. Roeters van Lennep , H. Tineke Westerveld , Henk W. O. Roeters van Lennep , Aelko H. Zwinderman , D. Willem Erkelens
DOI: 10.1161/01.ATV.20.11.2408
关键词:
摘要: Abstract—The effect of untreated total cholesterol (TC) and low density lipoprotein (LDL-C) as cardiovascular risk factors in both primary secondary prevention has been extensively ...
sci-hub.se 参考文章(39)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels The New England Journal of Medicine. ,vol. 339, pp. 1349- 1357 ,(1998) , 10.1056/NEJM199811053391902
Michael S Lauer, Eugene H Blackstone, James B Young, Eric J Topol, Cause of death in clinical research: Time for a reassessment? Journal of the American College of Cardiology. ,vol. 34, pp. 618- 620 ,(1999) , 10.1016/S0735-1097(99)00250-8
H. Tineke Westerveld, Jeanine E. Roeters van Lennep, Henk W. O. Roeters van Lennep, An-Ho Liem, Job A. J. de Boo, Yvonne T. van der Schouw, D. Willem Erkelens, Apolipoprotein B and Coronary Artery Disease in Women A Cross-sectional Study in Women Undergoing Their First Coronary Angiography Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 18, pp. 1101- 1107 ,(1998) , 10.1161/01.ATV.18.7.1101
A D Sniderman, K Cianflone, Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias. Clinical Chemistry. ,vol. 42, pp. 489- 491 ,(1996) , 10.1093/CLINCHEM/42.4.489
DAVID R. JACOBS, IRMA L. MEBANE, SHRIKANT I. BANGDIWALA, MICHAEL H. CRIQUI, HERMAN A. TYROLER, , HIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY American Journal of Epidemiology. ,vol. 131, pp. 32- 47 ,(1990) , 10.1093/OXFORDJOURNALS.AJE.A115483
T. O’Brien, T. T. Nguyen, B. J. Hallaway, D. Hodge, K. Bailey, D. Holmes, B. A. Kottke, The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 15, pp. 228- 231 ,(1995) , 10.1161/01.ATV.15.2.228
Gunnar Fager, Olov Wiklund, Cholesterol reduction and clinical benefit. Are there limits to our expectations Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 17, pp. 3527- 3533 ,(1997) , 10.1161/01.ATV.17.12.3527
S. Acton, A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, M. Krieger, Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor Science. ,vol. 271, pp. 518- 520 ,(1996) , 10.1126/SCIENCE.271.5248.518
Benoiˆt Lamarche, Sital Moorjani, Paul J. Lupien, Bernard Cantin, Paul-Marie Bernard, Gilles R. Dagenais, Jean-Pierre Despre´s, Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study Circulation. ,vol. 94, pp. 273- 278 ,(1996) , 10.1161/01.CIR.94.3.273
Alberto Zambon, John E. Hokanson, B. Greg Brown, John D. Brunzell, Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression Hepatic Lipase–Mediated Changes in LDL Density Circulation. ,vol. 99, pp. 1959- 1964 ,(1999) , 10.1161/01.CIR.99.15.1959